Live Price
Live Volume
Chart Volume 0
Volume 0
5 secInhibrx Market Segments
Overnight
*No Trades in Segment
After Hours
*No Trades in Segment
Regular Trading Hours
*No Trades in Segment
Premarket
*No Trades in Segment
After Hours Yesterday
+0.00(+0.00%)
| Open | $100.08 |
|---|---|
| Close | $100.08 |
| Low | $100.08 |
| Low Change | 0.00 (0.00%) |
| High | $100.08 |
| High Change | +0.00 (+0.00%) |
| Range | $0.00 |
| Volume | 114.288K |
| Dollar Volume | $11.44M |
Regular Trading Hours Yesterday
-5.58(-5.28%)
| Open | $105.67 |
|---|---|
| Close | $100.09 |
| Low | $100.08 |
| Low Change | -5.59 (-5.29%) |
| High | $106.94 |
| High Change | +1.27 (+1.20%) |
| Range | $6.86 |
| Volume | 223.527K |
| Dollar Volume | $22.37M |
Premarket Yesterday
*No Trades in Segment
Inhibrx News
3 weeks agoinvesting.comInhibrx stock jumps on positive cancer drug trial results
- 4 months agoinvesting.com
Inhibrx Biosciences stock gains after FDA accepts drug filing
- 5 months agoinvesting.com
Inhibrx Biosciences reports positive Ph2 trial data, stock gains
- 5 months agoinvesting.com
Inhibrx Biosciences stock surges on takeover interest report
9 months agobenzinga.comWhy Inhibrx's Recent Strength May Not Be Built to Last
Inhibrx Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Inhibrx Moving Averages
| 5 Day Moving Average (SMA5) | $101.32 |
|---|---|
| 10 Day Moving Average (SMA10) | $104.45 |
| 20 Day Moving Average (SMA20) | $108.87 |
| 50 Day Moving Average (SMA50) | $101.54 |
| 100 Day Moving Average (SMA100) | $100.08 |
| 200 Day Moving Average (SMA200) | $90.87 |
Inhibrx Statistics
| Average Volume (30 Days) | 345.42K |
|---|---|
| P/E Ratio (Current) | -11.16 |
| EPS (Current) | -$9.39 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$131.90M |
| Cash Ratio | 4.75 |
| Current Ratio | 5.07 |
| Quick Ratio | 5.07 |
| Debt to Equity | -3.33 |
| Enterprise Value | $1.59B |
| EV to EBITDA | -12.63 |
| EV to Sales | — |
| Price to Book | -29.12 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.90% |
| Return on Equity | 2.61% |
Inhibrx Stock Splits
There have been no stock splits for Inhibrx (INBX).
Inhibrx Dividends
There have been no dividends for Inhibrx (INBX).